NEW YORK, March 4, 2024 /PRNewswire/ — ANEW MEDICAL, INC. (“ANEW” or “the Company”) (OTCPK: LEAS) a US-based biotechnology company (“ANEW”) focused on developing cell and gene- based treatments to affect aging and age-related diseases, announced that is has been granted and issued a…
ANEW MEDICAL ANNOUNCES KEY PATENT ISSUED IN CHINA TO PROTECT KLOTHO PROTEIN AND GENE DELIVERY SYSTEMS
This post was originally published on this site